Who invested in Taysha Gene Therapies?
Taysha Gene Therapies's investors include B Capital, RA Capital Management, BlackRock, Franklin Templeton and Perceptive Advisors, and 1 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$400Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
From Taysha Gene Therapies's own website and the SEC filings it signed: 8 on the team.
On the board, as filediKathleen P. ReapeLaura P. Sepp-LorenzinoPhillip P. Donenberg
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Taysha Gene Therapies's investors include B Capital, RA Capital Management, BlackRock, Franklin Templeton and Perceptive Advisors, and 1 more on record.
Taysha Gene Therapies has raised $400M across 2 rounds since 2025.
Taysha Gene Therapies's most recent round was an Undisclosed round of $200M in Jun 2026.
Its most recent round, $200M in Jun 2026, is also its largest on record.
Taysha Gene Therapies's first round on record, in May 2025, was backed by B Capital, RA Capital Management and BlackRock and 2 others.
Taysha Gene Therapies's latest named round is an Undisclosed round, in Jun 2026.
Taysha Gene Therapies is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.